Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality
Overproduction of inflammatory cytokines is a keystone event in COVID-19 pathogenesis; TNF and its receptors (TNFR1 and TNFR2) are critical pro-inflammatory molecules. ADAM17 releases the soluble (sol) forms of TNF, TNFR1, and TNFR2. This study evaluated TNF, TNFRs, and ADAM17 at the protein, transc...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8423 |
id |
doaj-548c2b52a25746d987e17121292baf9d |
---|---|
record_format |
Article |
spelling |
doaj-548c2b52a25746d987e17121292baf9d2021-08-26T13:51:23ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-01228423842310.3390/ijms22168423Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to MortalityYadira Palacios0Andy Ruiz1Lucero A. Ramón-Luing2Ranferi Ocaña-Guzman3Omar Barreto-Rodriguez4Anahí Sánchez-Monciváis5Brenda Tecuatzi-Cadena6Ana G. Regalado-García7Rey David Pineda-Gudiño8Alicia García-Martínez9Fortunato Juárez-Hernández10Juan Pablo Farias-Contreras11Ingrid Fricke-Galindo12Gloria Pérez-Rubio13Ramcés Falfán-Valencia14Ivette Buendia-Roldan15Karen Medina-Quero16Leslie Chavez-Galan17Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoLaboratorio de Inmunología, Escuela Militar de Graduados de Sanidad, SEDENA, Mexico City 11200, MexicoLaboratorio de Inmunología, Escuela Militar de Graduados de Sanidad, SEDENA, Mexico City 11200, MexicoLaboratorio de Inmunología, Escuela Militar de Graduados de Sanidad, SEDENA, Mexico City 11200, MexicoHospital Central Militar, SEDENA, Mexico City 11200, MexicoHospital Central Militar, SEDENA, Mexico City 11200, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoLaboratorio de Inmunología, Escuela Militar de Graduados de Sanidad, SEDENA, Mexico City 11200, MexicoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, MexicoOverproduction of inflammatory cytokines is a keystone event in COVID-19 pathogenesis; TNF and its receptors (TNFR1 and TNFR2) are critical pro-inflammatory molecules. ADAM17 releases the soluble (sol) forms of TNF, TNFR1, and TNFR2. This study evaluated TNF, TNFRs, and ADAM17 at the protein, transcriptional, and gene levels in COVID-19 patients with different levels of disease severity. In total, 102 patients were divided into mild, moderate, and severe condition groups. A group of healthy donors (HD; <i>n</i> = 25) was included. Our data showed that solTNFR1 and solTNFR2 were elevated among the COVID-19 patients (<i>p</i> < 0.0001), without increasing the transcriptional level. Only solTNFR1 was higher in the severe group as compared to the mildly ill (<i>p</i> < 0.01), and the level was higher in COVID-19 patients who died than those that survived (<i>p</i> < 0.0001). The solTNFR1 level had a discrete negative correlation with C-reactive protein (<i>p</i> = 0.006, Rho = −0.33). The solADAM17 level was higher in severe as compared to mild disease conditions (<i>p</i> < 0.01), as well as in COVID-19 patients who died as compared to those that survived (<i>p</i> < 0.001). Additionally, a potential association between polymorphism <i>TNFRSF1A</i>:rs767455 and a severe degree of disease was suggested. These data suggest that solTNFR1 and solADAM17 are increased in severe conditions. solTNFR1 should be considered a potential target in the development of new therapeutic options.https://www.mdpi.com/1422-0067/22/16/8423COVID-19solTNFsolTNFR1solTNFR2ADAM17severity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yadira Palacios Andy Ruiz Lucero A. Ramón-Luing Ranferi Ocaña-Guzman Omar Barreto-Rodriguez Anahí Sánchez-Monciváis Brenda Tecuatzi-Cadena Ana G. Regalado-García Rey David Pineda-Gudiño Alicia García-Martínez Fortunato Juárez-Hernández Juan Pablo Farias-Contreras Ingrid Fricke-Galindo Gloria Pérez-Rubio Ramcés Falfán-Valencia Ivette Buendia-Roldan Karen Medina-Quero Leslie Chavez-Galan |
spellingShingle |
Yadira Palacios Andy Ruiz Lucero A. Ramón-Luing Ranferi Ocaña-Guzman Omar Barreto-Rodriguez Anahí Sánchez-Monciváis Brenda Tecuatzi-Cadena Ana G. Regalado-García Rey David Pineda-Gudiño Alicia García-Martínez Fortunato Juárez-Hernández Juan Pablo Farias-Contreras Ingrid Fricke-Galindo Gloria Pérez-Rubio Ramcés Falfán-Valencia Ivette Buendia-Roldan Karen Medina-Quero Leslie Chavez-Galan Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality International Journal of Molecular Sciences COVID-19 solTNF solTNFR1 solTNFR2 ADAM17 severity |
author_facet |
Yadira Palacios Andy Ruiz Lucero A. Ramón-Luing Ranferi Ocaña-Guzman Omar Barreto-Rodriguez Anahí Sánchez-Monciváis Brenda Tecuatzi-Cadena Ana G. Regalado-García Rey David Pineda-Gudiño Alicia García-Martínez Fortunato Juárez-Hernández Juan Pablo Farias-Contreras Ingrid Fricke-Galindo Gloria Pérez-Rubio Ramcés Falfán-Valencia Ivette Buendia-Roldan Karen Medina-Quero Leslie Chavez-Galan |
author_sort |
Yadira Palacios |
title |
Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality |
title_short |
Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality |
title_full |
Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality |
title_fullStr |
Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality |
title_full_unstemmed |
Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality |
title_sort |
severe covid-19 patients show an increase in soluble tnfr1 and adam17, with a relationship to mortality |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-08-01 |
description |
Overproduction of inflammatory cytokines is a keystone event in COVID-19 pathogenesis; TNF and its receptors (TNFR1 and TNFR2) are critical pro-inflammatory molecules. ADAM17 releases the soluble (sol) forms of TNF, TNFR1, and TNFR2. This study evaluated TNF, TNFRs, and ADAM17 at the protein, transcriptional, and gene levels in COVID-19 patients with different levels of disease severity. In total, 102 patients were divided into mild, moderate, and severe condition groups. A group of healthy donors (HD; <i>n</i> = 25) was included. Our data showed that solTNFR1 and solTNFR2 were elevated among the COVID-19 patients (<i>p</i> < 0.0001), without increasing the transcriptional level. Only solTNFR1 was higher in the severe group as compared to the mildly ill (<i>p</i> < 0.01), and the level was higher in COVID-19 patients who died than those that survived (<i>p</i> < 0.0001). The solTNFR1 level had a discrete negative correlation with C-reactive protein (<i>p</i> = 0.006, Rho = −0.33). The solADAM17 level was higher in severe as compared to mild disease conditions (<i>p</i> < 0.01), as well as in COVID-19 patients who died as compared to those that survived (<i>p</i> < 0.001). Additionally, a potential association between polymorphism <i>TNFRSF1A</i>:rs767455 and a severe degree of disease was suggested. These data suggest that solTNFR1 and solADAM17 are increased in severe conditions. solTNFR1 should be considered a potential target in the development of new therapeutic options. |
topic |
COVID-19 solTNF solTNFR1 solTNFR2 ADAM17 severity |
url |
https://www.mdpi.com/1422-0067/22/16/8423 |
work_keys_str_mv |
AT yadirapalacios severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT andyruiz severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT luceroaramonluing severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT ranferiocanaguzman severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT omarbarretorodriguez severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT anahisanchezmoncivais severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT brendatecuatzicadena severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT anagregaladogarcia severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT reydavidpinedagudino severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT aliciagarciamartinez severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT fortunatojuarezhernandez severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT juanpablofariascontreras severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT ingridfrickegalindo severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT gloriaperezrubio severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT ramcesfalfanvalencia severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT ivettebuendiaroldan severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT karenmedinaquero severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality AT lesliechavezgalan severecovid19patientsshowanincreaseinsolubletnfr1andadam17witharelationshiptomortality |
_version_ |
1721192690790432768 |